Factores que influyen en la aparición de la nefropatía diabética incipiente: estudio ESODIAH

Mogensen, 1984, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset of diabetes, N Engl J Med, 310, 356, 10.1056/NEJM198402093100605 Weir, 2004, Microalbuminuria in type 2 diabetics: An important, overlooked cardiovascular risk factor, J Clin Hypertens, 6, 134, 10.1111/j.1524-6175.2004.02524.x Dineen, 1997, The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus, Arch Int Med, 157, 1413, 10.1001/archinte.157.13.1413 1999 Torffvit, 2001, The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients, J Diabetes Complications, 15, 307, 10.1016/S1056-8727(01)00176-3 1998, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38), BMJ, 317, 703, 10.1136/bmj.317.7160.703 Tonoto, 1997, Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment, Diabetes Care, 20, 1891, 10.2337/diacare.20.12.1891 Kanauchi, 2002, Cigarette smoking affects tubulointerstitial lesions in type 2 diabetes, Diabetes Care, 25, 1486, 10.2337/diacare.25.8.1486-a Orth, 2002, Smoking and the kidney, J Am Soc Nephrol, 13, 1663, 10.1097/01.ASN.0000018401.82863.FD Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2002;25 Suppl 1:5-20. Molitch, 2004, American Diabetes Association. Nephropathy in diabetes, Diabetes Care, 27, 79 Lam, 1995, Cholesterol-lowering therapy may retard the progression of diabetic nephropathy, Diabetologia, 38, 604, 10.1007/BF00400731 Grandaliano, 1983, Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells, Kidney Int, 44, 503, 10.1038/ki.1993.274 O’Donnel, 1993, Lovastatin inhibits proliferation of rat mesangial cells, J Clin Invest, 91, 83, 10.1172/JCI116204 Hammad, 2003, Nephropathy in a hypercholesterolemic mouse with streptozotocin-induced diabetes, Kidney Blood Press Res, 26, 351, 10.1159/000073942 Esmatjes, 1996, Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia. The Catalan Diabetic Nephropathy Study Group, Diabetes Res Clin Pract, 32, 157, 10.1016/0168-8227(96)01256-9 Ruilope, 2002, Protección renal en la diabetes mellitus tipo 2, Med Clin (Barc), 118, 312, 10.1016/S0025-7753(02)72364-6 Martín, 2002, Nefropatía diabética, Med Clin (Barc), 118, 297 Gambaro, 2001, Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus, Diabetes Nutr Metab, 14, 337 Esmatjes, 2002, Incidence of diabetic nephropathy in type 1 diabetic patients in Spain: «Estudio Diamante», Diabetes Res Clin Pract, 57, 35, 10.1016/S0168-8227(02)00007-4